Is Repligen Corporation (RGEN) A Smart Long-Term Choice?

Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly net return of 2.86% was recorded by the fund for the fourth quarter of 2021, beating its Benchmark, the MSCI All Country World Small Cap Index, which returned 2.22% for the same period. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022.

Harding Loevner Global Small Companies Equity Fund, in its Q4 2021 investor letter, mentioned Repligen Corporation (NASDAQ: RGEN) and discussed its stance on the firm. Repligen Corporation is a Waltham, Massachusetts-based bioprocessing company with a $10.7 billion market capitalization. RGEN delivered a -26.37% return since the beginning of the year, while its 12-month returns are up by 6.44%. The stock closed at $195.01 per share on March 02, 2022.

Here is what Harding Loevner Global Small Companies Equity Fund has to say about Repligen Corporation in its Q4 2021 investor letter:

Repligen, a leading provider of filtration equipment used in manufacturing biologics, experienced accelerating growth due to strong demand for COVID-19 vaccines and antibody therapies. Demand for surgical ophthalmology equipment bounced back as patients rescheduled procedures that had been deferred in 2020, helping Switzerland-based Carl Zeiss Meditec.”

Easiest Md/PhD Programs to Get Into

Pressmaster/Shutterstock.com

Our calculations show that Repligen Corporation (NASDAQ: RGEN) failed to obtain a mark on our list of the 30 Most Popular Stocks Among Hedge Funds. RGEN was in 37 hedge fund portfolios at the end of the fourth quarter of 2021, compared to 35 funds in the previous quarter. Repligen Corporation (NASDAQ: RGEN) delivered a -27.46% return in the past 3 months.

In December 2021, we also shared another hedge fund’s views on RGEN in another article. You can find other letters from hedge funds and prominent investors on our hedge fund investor letters 2021 Q4 page.

Disclosure: None. This article is originally published at Insider Monkey.